Antiemetic activity of the new 5-HT3 antagonist DAU 6215 in animal models of cancer chemotherapy and radiation. [electronic resource]
Producer: 19911218Description: 470-4 p. digitalISSN:- 0344-5704
- Animals
- Antiemetics -- therapeutic use
- Benzimidazoles -- therapeutic use
- Bridged Bicyclo Compounds -- therapeutic use
- Bridged Bicyclo Compounds, Heterocyclic
- Cisplatin -- adverse effects
- Disease Models, Animal
- Dogs
- Dose-Response Relationship, Drug
- Doxorubicin -- adverse effects
- Drug Evaluation, Preclinical
- Female
- Ferrets
- Imidazoles -- therapeutic use
- Male
- Metoclopramide -- therapeutic use
- Neoplasms, Experimental -- complications
- Ondansetron
- Serotonin Antagonists -- therapeutic use
- Time Factors
- Vomiting -- etiology
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.